Association between diet quality, lipid profile and body weight in participants with spinal injury

Not Applicable

• Conditions: Spinal Cord injury; Cardiovascular disease; Public Health - Health promotion/education; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system; Neurological - Other neurological disorders; Injuries and Accidents - Other injuries and accidents

• Registration Number: ACTRN12620000196943
• Lead Sponsor: Priya Iyer

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-19
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

All adult inpatients admitted to the spinal injury rehabilitation unit, with or without existing CVD risk/disease at Royal Rehab consenting to participate will be included in this study.

Exclusion Criteria

1.Community dwelling individuals with spinal cord injury and inpatients in acute care facilities will be excluded from this study.
2.Participants who decline or refuse to participate in the study. Refusal to participate in the study will in no way affect their treatment and these individuals will still receive regular services from the Nutrition and Dietetics team at the facility. These participants also have the liberty to opt for the cardo-diet choice, should they prefer even during non-enrolment into the study.
3.Patients with concurrent or a history of traumatic brain injury with cognitive impairment interfering with their ability to understand the requirements of the study.
4.Patients on enteral feeding or very low energy diet (e.g. Optifast) will be excluded.
5.Patients with grade 2 or above pressure injuries will be excluded.
6.Patients with a pacemaker, those who are either pregnant or breast-feeding will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diet quality using MEDAS tool [Baseline (week 0 as primary timepoint) and at intervals of 4, 8, and 12 weeks and once post discharge from the facility (~6-8 weeks)];Lipid profile<br>Biochemistry evaluation will be ordered by the medical staff and completed at the facility’s accredited pathology labs as is usually done part of standard care. Fasting blood samples will be taken from patients to measure lipids (total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL) and triglycerides).Biochemistry review in the community will be arranged by the medical specialist and completed by the patient’s General Practitioner. If patients are discharged home prior, follow-up will be completed in the community for that period. [Baseline (primary timepoint), 12 weeks and 6-8 weeks post discharge];Body weight<br>Body weight will be measured to 0.1kg using Seca 664 wheelchair, digital scales. [Baseline (primary timepoint), 4, 8 and 12 weeks and 6-8 weeks post discharge]